ArticleInternal medicine (Tokyo, Japan)2020

Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus.

Misato Jono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.